IRDOpus Genetics, Inc.
$4.45+119% 1Y
$4.45
$1.7452 weeks$6.09
The financials
Opus Genetics, Inc. by the numbers
Opus Genetics, Inc. (IRD) reported revenue of $755K in Q2 2026 (quarter ended Jun 30, 2026), down 74% from the same quarter a year earlier. That came with net loss of $8.1M. For the full year FY2025, revenue was $14M (+29% year on year) and net income −$50M. The next results filing is expected around Nov 11, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $755K | $2.9M | −74% |
| Operating income | −$16M | −$8.9M | n/a |
| Net income | −$8.1M | −$7.4M | n/a |
| Diluted EPS | −$0.14 | −$0.12 | n/a |